Image

North America Cancer Spit Test Device Market – Industry Trends and Forecast to 2028

Healthcare

Image

North America Cancer Spit Test Device Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • North America
  • 350 Pages
  • No of Tables: 78
  • No of Figures: 49

North America Cancer Spit Test Device Market, By Product Type (Saliva Collection Kits, Fluid Specific Devices, Oral Swab, Bar-Code Labels, Saliva Cryostorage Box and Others), Site Of Collection (Sub-Mandibular/Sub-Lingual Gland, Parotid Gland And Minor Salivary Gland), Application (Liver-Lung Cancer, Breast Cancer, Colon and Rectal Cancer, Prostate Cancer, Pancreatic Cancer, Oral Cancer, Thyroid Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Melanoma, Non-Hodgkin Lymphoma, and Others), Age Group (Adult and Pediatrics), Method Of Collection (Passive Drool, Oral Swab and Others), End User (Hospitals, Diagnostic Laboratories, Oncology Specialty Clinics, Cancer Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2028.

North America Cancer Spit Test Device Market Market Analysis and Insights: North America Cancer Spit Test Device Market

North America cancer spit test device market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the North America cancer spit test device market is growing with a CAGR of 10.0% in the forecast period of 2021 to 2028 and is expected to reach USD 473.28 million by 2028 from USD 230.06 million in 2020. Rising prevalence of chronic diseases and increasing of cancer patients are the major drivers, which are expected to propel the growth of the market in the forecast period.

A saliva test is extensively used for cancer detection. A cancer saliva would test for the presence or absence of mutated extra-cellular DNA and RNA. The tumor cells shed DNA and RNA into the circulation and they come into saliva, and mutations are detectable with great accuracy in saliva.

The cancer saliva test devices market comprises testing kits, swabs, cassettes, and devices used for the detection of drugs, infections, or diseases in human beings. Several types of kits utilize different types of molecular biology methods for disease detection. ELISA, PCR, immunoassay, and enzymatic assays among others are molecular techniques that are used for saliva testing.

The North America cancer spit test device market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

North America Cancer Spit Test Device Market North America Cancer Spit Test Device Market Scope and Market Size

North America cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the North America cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to increasing demand for POCT devices and rising prevalence of cancer patients in the region. .
  • On the basis of site of collection, the North America cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to surging pool of cancer patients and increasing healthcare expenditure.
  • On the basis of application, the North America cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market because of changing lifestyle and rising incidences of liver cirrhosis.
  • On the basis of age group, the North America cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market because of increasing geriatric population and rising prevalence of chronic diseases in the region.
  • On the basis of method of collection, the North America cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market because it is stored and collected with better patient compliance.
  • On the basis of end user, the North America cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market because of growing awareness among people about cancer and its treatment.
  • On the basis of distribution channel, the North America cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to rising healthcare expenditure and easy accessibility of products.

North America Cancer Spit Test Devices Market Country Level Analysis

The North America cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.

Countries covered in the North America cancer spit test device market report are the U.S., Canada, and Mexico. North America is expected to dominate the cancer spit test devices market due to rising prevalence of chronic diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the North America Cancer Spit Test Devices Market

Saliva collection kits segment in the U.S. is expected to grow with the highest rate and is dominating North America region in the forecast period of 2021 to 2028 owing to rising prevalence of cancer in the country.

North America cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the North America cancer spit test device market sales, impact of advancement in the North America cancer spit test device market and changes in regulatory scenarios with their support for the North America cancer spit test devices market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and North America Cancer Spit Test Device Market Share Analysis

North America cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to North America cancer spit test devices market.

Major players covered in the report are DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG,  Miraclean Technology Co., Ltd.,  Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd,  Oasis Diagnostics Corporation, Canvax ( a subsidiary of dobuss) among others domestic and North America players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launchs and agreements are also initiated by the companies worldwide, which are further accelerating the North America cancer spit test device market growth.

For instance,

  • In January 2021, DNA Genotek announced that the U.S. Food and Drug Administration (FDA) has granted a general use 510(k) clearance for its OrageneDx family of products. This FDA approval has increased the credibility of the company in the market and increased the demand for this product.
  • In February 2021, Thermo Fisher Scientific was recognized with six CMO Leadership Awards. It won across all six categories including capabilities, compatibility, expertise, quality, reliability, and service. This is the second consecutive year Thermo Fisher has received this recognition across all six categories and the eighth time overall that the company has been honored by the CMO Leadership Awards. This has increased the credibility of the company and aided in revenue generation.


SKU-

LIST OF TABLES 

TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.

TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.

TABLE 3 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 55 U.S. CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.S. SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 57 U.S. CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 58 U.S. CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 U.S. CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 60 U.S. CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 61 U.S. CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 U.S. CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 63 CANADA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 CANADA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 65 CANADA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 66 CANADA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 CANADA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 68 CANADA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 69 CANADA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 CANADA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 MEXICO CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 MEXICO SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 73 MEXICO CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 74 MEXICO CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 MEXICO CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)

TABLE 76 MEXICO CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)

TABLE 77 MEXICO CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 MEXICO CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials